Poolbeg Pharma plc is a biopharmaceutical company committed to the development and commercialisation of innovative medicines that address critical unmet medical needs with a growing emphasis on rare and orphan diseases. We are focussed upon developing a number of compelling clinical assets while strategically commercialising approved and marketed drugs to fund the development of our robust pipeline of high value products.
Learn morePipeline
Our high impact clinical programmes target areas of high unmet need including cancer immunotherapy-induced CRS, infectious disease, and metabolic conditions such as obesity with the development of an oral GLP-1R agonist. By leveraging innovative technologies, such as artificial intelligence, we have accelerated drug discovery making it more efficient and increasing the likelihood of success compared to traditional methods.
learn more